ArticleTuberculosis and respiratory diseases2022

Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline: Authors' Reply.

Yewon Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.